Application of Concentrated Growth Factors in Alveolar Ridge Preservation

Study on the Effect of Concentrated Growth Factor in Promoting the Regeneration and Preservation of Soft and Hard Tissues

To explore the role of CGF in the regeneration or preservation of soft and hard tissues during tooth extraction site preservation surgery.

Study Overview

Detailed Description

A prospective, randomized controlled trial is designed to explore the role of CGF in the regeneration or preservation of soft and hard tissues in extraction site preservation. Using random number table, 20 patients were randomly divided into 4 groups using different filling materials in the extraction socket and materials for the wound sealing. Group A (5cases): bone powder + collagen membrane; Group B (5 cases): bone powder + collagen membrane + CGF membrane; Group C (5 cases): bone powder mixed CGF gel + collagen membrane + CGF membrane; Group D (5 cases): bone powder + CGF membrane.

Extraction and site preservation surgery were performed by the same physician and clinical follow-up was more than 6 months after surgery. The four groups will be compared on several variables, including the changes in pain score, Landry wound healing index, membrane exposure area, keratinized gingival width, buccolingual gingival width, alveolar crest width and height.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang Procince
      • Yiwu, Zhejiang Procince, China, 310000
        • Recruiting
        • The Fourth Affiliated Hospital Zhejiang University School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Voluntarily participate in this trial and sign a written informed consent; Patients aged 25 ≤ age ≤ 45 years; The combination of intraoral and imaging examinations confirms that the affected tooth has no preservation value, requires tooth extraction, and the patient is willing to use site preservation; No progressive periodontal disease or acute apical periodontitis in the affected teeth; No long-term history of oral bisphosphonates; Non smoking patients; No systemic diseases such as diabetes and hypertension.

Exclusion Criteria:

Patients who have difficulty tolerating surgery; Patients under 25 years old or above 45 years old; The whole body is accompanied by hypertension, diabetes and other serious systemic diseases, which need to be controlled by drugs; Patients who take oral medication that affects bone metabolism for at least one month due to the need for disease treatment; Patients who take medication that may affect platelet function was used within 3 months due to the need for disease treatment; Patients unable to undergo X-ray imaging examination due to pregnancy or preparation after site preservation surgery; Patients who Smoke; The apical and periodontal inflammation is in the acute phase (purulent phase) Regular follow-up or follow-up for more than 6 months is not allowed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: bone powder + collagen membrane
Fill the extraction socket with bone powder, and cover the extraction wound with collagen membrane.
Fill the extraction socket with Bio-Oss® bone powder, and cover the extraction wound with Bio-Gide® collagen membrane.
Experimental: bone powder + collagen membrane + CGF membrane
Fill the extraction socket with bone powder, and cover the extraction wound with collagen membrane and CGF membrane.
Fill the extraction socket with Bio-Oss® bone powder, and cover the extraction wound with Bio-Gide® collagen membrane plus CGF membrane(CGF gel is pressed into a film)
Experimental: bone powder mixed wih CGF gel + collagen membrane + CGF membrane
Fill the extraction socket with bone powder mixed with CGF gel, and cover the extraction wound with collagen membrane and CGF membrane.
Fill the extraction socket with Bio-Oss® bone powder mixed with CGF gel (CGF gel is cutted into granules ), and cover the extraction wound with Bio-Gide® collagen membrane plus CGF membrane(CGF gel is pressed into a film)
Experimental: bone powder + CGF membrane
Fill the extraction socket with bone powder, and cover the extraction wound with CGF membrane.
Fill the extraction socket with Bio-Oss® bone powder and cover the extraction wound with CGF membrane(CGF gel is pressed into a film)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the width of keratinized gingiva
Time Frame: preoperative, 3 months and 6 months after surgery
the width of keratinized gingiva measured by periodontal probe
preoperative, 3 months and 6 months after surgery
the horizontal width (from buccal to lingual at the alveolar top ) of gingiva
Time Frame: immediate , 3 months and 6 months postoperative
the horizontal width of gingiva measured by periodontal probe
immediate , 3 months and 6 months postoperative
the horizontal bone resorption of alveolar crest
Time Frame: immediate , 3 months and 6 months postoperative
Compared with immediate postoperative, the horizontal width of alveolar crest decreased at 3months and 6 months, postoperative alveolar bone resorption progressed with time
immediate , 3 months and 6 months postoperative
the vertical bone resorption of alveolar crest
Time Frame: immediate , 3 months and 6 months postoperative
the vertical width of alveolar crest decreased at 3months and 6 months postoperative compared with the immediate postoperative
immediate , 3 months and 6 months postoperative
the average gray value of alveolar bone
Time Frame: immediate , 3 months and 6 months postoperative
the average gray value of alveolar bone
immediate , 3 months and 6 months postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Landry wound healing index
Time Frame: 7 days and 12 days after surgery
scores:1,2,3,4,5 according to the gingival healing status
7 days and 12 days after surgery
reduction in membrane exposure area
Time Frame: 7 days,12 days and one month after surgery
membrane exposure area reduce different in four groups
7 days,12 days and one month after surgery
pain score
Time Frame: 1day, 3days after surgerys
scores: 2,4,6,8,10 using the Wong-Baker facial pain scale revision (FPS-R)
1day, 3days after surgerys

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Genying Zhuang, Master, The Fourth Affiliated Hospital Zhejiang University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 9, 2023

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

March 7, 2024

First Submitted That Met QC Criteria

March 7, 2024

First Posted (Actual)

March 13, 2024

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 7, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Ridge Preservation

Clinical Trials on bone powder + collagen membrane

3
Subscribe